跳至主要内容
临床试验/DRKS00026082
DRKS00026082进行中(未招募)未知

Cytokine adsorption in patients with acute on chronic liver failure (CYTOHEP) – a single center, open-label, randomized, controlled intervention trial - CYTOHEP

niversitätsklinikum Freiburg Department Innere Medizin Klinik für Innere Medizin III0 个研究点目标入组 9 人开始时间: 2021年8月24日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
9

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Adult patients (= 18 years) admitted to the University Medical Center Freiburg, Germany
  • - acute-on-chronic liver failure (ACLF) WITH
  • a) acute kidney injury according to Kidney Disease: Improving Global Outcome (KDIGO) criteria stage 3 (= 3-fold increase of serum creatinine OR increase of serum creatinine to = 4 mg/dl OR urine output = 0.3 ml/kg/h for = 24 hours OR anuria for = 12 hours) AND
  • b) serum bilirubin = 5 mg/dl

排除标准

  • - known patient will against participation in the study or against the measures applied in the study
  • - a decision made prior to inclusion to stop further treatment of the patient within the next 24 hours
  • - no complete remission of malignancy including hepatocellular carcinoma within the past 12 months
  • - patients on the waiting list for liver transplant or the potential option for being listed for liver transplant within the next 6 months
  • - liver cirrhosis in patients after liver transplantation
  • - ongoing intermittent or continuous renal replacement therapy before study inclusion

研究者

发起方
niversitätsklinikum Freiburg Department Innere Medizin Klinik für Innere Medizin III

相似试验